Spero Biopharma

Spero Biopharma is an Israeli biopharmaceutical company focused on developing treatments for neurological disorders and other diseases.

Health Tech & Life Sciences
Active
Pre-Funding Israel Founded 2019
Website ↗
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
2019
Headcount
1-10
HQ
Israel
Sector
Health Tech & Life Sciences

About

Spero Biopharma Ltd. was founded by Prof. Marta Weinstock-Rosin, known for inventing Exelon®, a drug for Alzheimer's disease. The company's leading compounds include SPE-100, an innovative treatment for Mild Cognitive Impairment (MCI) which has completed Phase 2, and SPE-200 for NASH.

Q&A

What is Spero Biopharma's primary focus?
Spero Biopharma focuses on the prevention and treatment of Alzheimer's Disease, specifically developing Ladostigil to treat mild cognitive impairment.
Where is Spero Biopharma headquartered?
Spero Biopharma is headquartered in Ramat HaSharon, Center District, Israel.
When was Spero Biopharma founded?
Spero Biopharma was founded in June 2019.
What is the current employee count for Spero Biopharma?
Spero Biopharma has 1-10 employees.
What is the current product stage of Spero Biopharma's main drug?
Spero Biopharma's main drug, Ladostigil, is currently in the clinical trial stage.
In which sector does Spero Biopharma primarily operate?
Spero Biopharma operates primarily in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
Does Spero Biopharma hold any patents?
Yes, Spero Biopharma holds 1 patent.
What is Spero Biopharma's current funding stage?
Spero Biopharma is currently in the Pre-Funding stage.

Team · 1

Prof. Marta Weinstock-Rosin
Founder · Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

alzheimers-diseasepharmaceuticalsneurologypharma-companiesdrug-discovery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesperobio.com/

Identifiers & details

Founded2019

Radar intelligence

Web history (Wayback)

Domainsperobio.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516044435
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2019-06-23
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2024
Active charges / liens0
Registry events1 — other (1)
Registered addressדרך חברון 101 ירושלים

Recent registry events

DateEvent
2025-12-16עדכון חיובים במג~ק